Amyloid-Related Imaging Abnormalities in 2 Phase 3 Studies Evaluating Aducanumab in Patients With Early Alzheimer DiseaseStephen Salloway, Karen Smirnakis, Jerome Barakos et al.|JAMA Neurology|2021Cited by 590
Steps to standardization and validation of hippocampal volumetry as a biomarker in clinical trials and diagnostic criterion for Alzheimer's diseaseClifford R. Jack, Norman L. Foster, Frederik Barkhof et al.|Alzheimer s & Dementia|2011Cited by 220